C
Crinetics Pharmaceuticals D
D
CRNX
30.990
USD
0.58
(1.92%)
مغلق
حجم التداول
0
الربح لكل سهم
-5
العائد الربحي
-
P/E
-8
حجم السوق
2,903,147,229
الأخبار المقالات
العنوان: Crinetics Pharmaceuticals
القطاع: Healthcare
الصناعة: Biotechnology
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.